J P McCormack

Summary

Affiliation: University of British Columbia
Country: Canada

Publications

  1. pmc Measuring hsCRP--an important part of a comprehensive risk profile or a clinically redundant practice?
    James P McCormack
    Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada
    PLoS Med 7:e1000196. 2010
  2. pmc Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs
    Alan Cassels
    School of Health Information Science, University of Victoria, Victoria, BC
    CMAJ 168:1133-7. 2003
  3. pmc Metformin's contraindications should be contraindicated
    James McCormack
    Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC
    CMAJ 173:502-4. 2005
  4. pmc Do beta-blockers have a role in treating hypertension? No
    James P McCormack
    Faculty of Pharmaceutical Sciences, UBC, Vancouver, BC V6Z 1Y6
    Can Fam Physician 53:614-21. 2007
  5. pmc Adding "value" to clinical practice guidelines
    James P McCormack
    Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver
    Can Fam Physician 53:1326-7. 2007
  6. pmc Rebuttal: Do beta-blockers have a role in treating hypertension? No
    James P McCormack
    Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver
    Can Fam Physician 53:800-3. 2007
  7. pmc Digging for data from the COX-2 trials
    James P McCormack
    CMAJ 166:1649-50. 2002
  8. ncbi request reprint Providing evidence-based information to patients in general practice and pharmacies: what is the acceptability, usefulness and impact on drug use?
    James P McCormack
    Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada
    Health Expect 6:281-9. 2003
  9. ncbi request reprint Outcomes of bupropion therapy for smoking cessation during routine clinical use
    Elan C Paluck
    Research and Performance Support, Regina Qu Appelle Health Region, Regina, Saskatchewan, Canada
    Ann Pharmacother 40:185-90. 2006

Collaborators

Detail Information

Publications9

  1. pmc Measuring hsCRP--an important part of a comprehensive risk profile or a clinically redundant practice?
    James P McCormack
    Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada
    PLoS Med 7:e1000196. 2010
  2. pmc Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs
    Alan Cassels
    School of Health Information Science, University of Victoria, Victoria, BC
    CMAJ 168:1133-7. 2003
    ..We assessed newspaper descriptions of drug benefits and harms, the nature of the effects described and the presence or absence of other important information that can add context and balance to a report about a new drug...
  3. pmc Metformin's contraindications should be contraindicated
    James McCormack
    Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC
    CMAJ 173:502-4. 2005
  4. pmc Do beta-blockers have a role in treating hypertension? No
    James P McCormack
    Faculty of Pharmaceutical Sciences, UBC, Vancouver, BC V6Z 1Y6
    Can Fam Physician 53:614-21. 2007
  5. pmc Adding "value" to clinical practice guidelines
    James P McCormack
    Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver
    Can Fam Physician 53:1326-7. 2007
    ....
  6. pmc Rebuttal: Do beta-blockers have a role in treating hypertension? No
    James P McCormack
    Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver
    Can Fam Physician 53:800-3. 2007
  7. pmc Digging for data from the COX-2 trials
    James P McCormack
    CMAJ 166:1649-50. 2002
  8. ncbi request reprint Providing evidence-based information to patients in general practice and pharmacies: what is the acceptability, usefulness and impact on drug use?
    James P McCormack
    Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada
    Health Expect 6:281-9. 2003
    ..However, the acceptability, utility and impact of evidence-based therapeutic guides on physicians, pharmacists and patients have not been well evaluated...
  9. ncbi request reprint Outcomes of bupropion therapy for smoking cessation during routine clinical use
    Elan C Paluck
    Research and Performance Support, Regina Qu Appelle Health Region, Regina, Saskatchewan, Canada
    Ann Pharmacother 40:185-90. 2006
    ....